Arabic Arabic English English French French German German
dark

Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories COVID-19 Tests

Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as a distributor of the LuSys Eagle Diagnostics test. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Global Rare Disease Drug Market Size Clinical Trials Insight 2028

Next Post

Bioengineered Nanoparticles Show Promise for Fibrinogen Manufacture, says Journal of Pharmaceutical Analysis Study

Related Posts
Total
0
Share